Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

124

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01XG03	NINLARO	B	Ixazomib - 2.3mg	2.3mg	Capsule, hard	272,619,919 L.L
L01XJ01	ERIVEDGE	B	Vismodegib - 150mg	150mg	Capsule	465,368,012 L.L
L01XK01	LYNPARZA	B	Olaparib - 150mg	150mg	Tablet, film coated	L.L
L01XK01	LYNPARZA	B	Olaparib - 100mg	100mg	Tablet, film coated	230,789,350 L.L
L01XK01	LYNPARZA	B	Olaparib - 150mg	150mg	Tablet, film coated	230,789,350 L.L
L01XK04	TALZENNA	B	Talazoparib - 1mg	1mg	Capsule	401,512,167 L.L
L01XK04	TALZENNA	B	Talazoparib - 0.25mg	0.25mg	Capsule	133,836,699 L.L
L01XK52	AKEEGA	B	Niraparib - 100mg, Abiraterone acetate - 500mg		Tablet, film coated	519,366,124 L.L
L01XK52	AKEEGA	B	Niraparib - 50mg, Abiraterone acetate - 500mg		Tablet, film coated	519,366,124 L.L
L01XX02	ERWINASE	BioTech	Erwinia L-asparaginase - 10,000IU	10,000IU	Injectable lyophilised powder for solution	444,434,845 L.L
L01XX02	SPECTRILA	BioTech	Asparaginase, recombinant - 10,000IU	10,000IU	Injectable powder for concentrate for solution	21,370,813 L.L
L01XX05	CUREAML	G	Hydroxycarbamide (or Hydroxyurea) - 500mg	500mg	Capsule	1,228,272 L.L
L01XX05	CYTODROX	G	Hydroxycarbamide (or Hydroxyurea) - 500mg	500mg	Capsule	3,301,821 L.L
L01XX05	UNIDREA	G	Hydroxycarbamide (or Hydroxyurea) - 500mg	500mg	Capsule, hard	2,539,862 L.L
L01XX24	ONCASPAR	B	Pegaspargase - 750U/ml	750U/ml	Injectable powder for solution	172,758,585 L.L
L01XX24	ONCASPAR	B	Pegaspargase - 750U/ml	750U/ml	Injectable powder for solution	L.L
L01XX35	ANAGRELIDE BIOGARAN	G	Anagrelide - 0.5mg	0.5mg	Capsule	15,754,068 L.L
L01XX41	HALAVEN	B	Eribulin mesylate - 0.88mg/2ml	0.88mg/2ml	Injectable solution	35,421,768 L.L
L01XX41	HALAVEN	B	Eribulin mesylate - 0.88mg/2ml	0.88mg/2ml	Injectable solution	L.L
L01XX44	ZALTRAP	BioTech	Aflibercept - 100mg/4ml	100mg/4ml	Injectable concentrate for solution	35,658,713 L.L
L01XX44	ZALTRAP	BioTech	Aflibercept - 100mg/4ml	100mg/4ml	Injectable concentrate for solution	35,658,713 L.L
L01XX44	ZALTRAP	BioTech	Aflibercept - 200mg/8ml	200mg/8ml	Injectable concentrate for solution	63,807,499 L.L
L01XX44	ZALTRAP	BioTech	Aflibercept - 200mg/8ml	200mg/8ml	Injectable concentrate for solution	63,807,499 L.L
L01XX52	VENCLEXTA	B	Venetoclax - 100mg	100mg	Tablet	707,858,935 L.L
L01XX52	VENCLEXTA	B	Venetoclax - 10mg week 1, Venetoclax - 50mg week 2, Venetoclax - 100mg week 3&4		Tablet	190,943,809 L.L
L01XX52	VENCLEXTA	B	Venetoclax - 100mg	100mg	Tablet	L.L
L01XX74	WELIREG	B	Belzutifan - 40mg	40mg	Tablet, film coated	1,550,772,301 L.L
L01XY02	PHESGO	BioTech	Pertuzumab - 600mg, Trastuzumab - 600mg		Injectable solution	326,054,156 L.L
L01XY02	PHESGO	BioTech	Pertuzumab - 1200mg, Trastuzumab - 600mg		Injectable solution	591,417,874 L.L
L02AE03	ZOLADEX DEPOT	B	Goserelin (acetate) - 3.6mg	3.6mg	Injectable suspension	8,820,074 L.L

...

124

...